Skip to content

Dexmedetomidine Alleviating Neurodevelopmental Injury in Infants Induced by Repeated Sevoflurane Exposure

Dexmedetomidine Alleviating Neurodevelopmental Injury in Infants Induced by Repeated Sevoflurane Exposure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121367
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-04-04
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodevelopmental Disorders

Interventions

Experimental group:Infuse normal saline containing 0.2 µg/mL dexmedetomidine at an infusion rate of 1 mL/kg/h
Control group:Normal saline was infused at a rate of 1 mL/kg/h intraoperatively.

Sponsors

Hunan Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: Patients aged 0 to 12 months who were scheduled to undergo two or more abdominal surgeries, with a single anesthesia duration exceeding 1 hour, and who received operations at Hunan Children's Hospital were enrolled.

Exclusion criteria

Exclusion criteria: Preterm infants (corrected gestational age < 37 weeks at the time of surgery), ASA physical status class ? or above, history of severe intrauterine hypoxia and asphyxia at birth, central nervous system diseases, severe hepatic and renal dysfunction, history of prior opioid use, history of prior inhalation anesthesia and sedation, contraindications to caudal anesthesia, contraindications to the use of dexmedetomidine (DEX), sevoflurane, cisatracurium and ropivacaine, as well as postoperative admission to the intensive care unit or requirement for mechanical ventilation.

Design outcomes

Primary

MeasureTime frame
ASQ-3,Ages & Stages Questionnaire- 3rd Edition;

Secondary

MeasureTime frame
Physical growth indicators;

Countries

China

Contacts

Public ContactDu Zhen

Hunan Children's Hospital

meggyzhen@163.com+86 731 8560 0952

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026